CYTOF — Altamira Therapeutics Income Statement
0.000.00%
Last trade - 00:00- $0.38m
- $0.74m
- $0.18m
- 40
- 82
- 16
- 43
Annual income statement for Altamira Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | R2021 December 31st | R2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F/A |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | fx Final | fx Final | fx Final | fx Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0.176 |
| Cost of Revenue | |||||
| Gross Profit | — | — | — | — | -0.015 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 7.31 | 5.63 | 7.52 | 18.9 | 2.1 |
| Operating Profit | -7.31 | -5.63 | -7.52 | -18.9 | -1.93 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.87 | -8.76 | -7.45 | -19.5 | -2.09 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -6.68 | -8.74 | -7.32 | -19.5 | -1.98 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -6.68 | -8.74 | -18.7 | -27.8 | -1.98 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.68 | -8.74 | -18.7 | -27.8 | -1.98 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -918 | -581 | -188 | -245 | -1.31 |